Alten R[au] - Search Results

Year	Number of Results
1978	1
1991	1
1992	2
1996	2
1997	1
1999	2
2000	2
2002	3
2003	2
2004	4
2005	3
2006	4
2007	5
2008	6
2009	7
2010	7
2011	9
2012	16
2013	11
2014	14
2015	11
2016	19
2017	20
2018	14
2019	16
2020	17
2021	10

1

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.

Kim H, Alten R, Avedano L, Dignass A, Gomollón F, Greveson K, Halfvarson J, Irving PM, Jahnsen J, Lakatos PL, Lee J, Makri S, Parker B, Peyrin-Biroulet L, Schreiber S, Simoens S, Westhovens R, Danese S, Jeong JH. Kim H, et al. Among authors: alten r. Drugs. 2020 Feb;80(2):99-113. doi: 10.1007/s40265-020-01256-5. Drugs. 2020. PMID: 32002851 Free PMC article. Review.

2

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.

Gabay C, Emery P, van Vollenhoven R, Dikranian A, Alten R, Pavelka K, Klearman M, Musselman D, Agarwal S, Green J, Kavanaugh A; ADACTA Study Investigators. Gabay C, et al. Among authors: alten r. Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18. Lancet. 2013. PMID: 23515142 Clinical Trial.

3

[Janus kinase inhibitors : State of the art in clinical use and future perspectives].

Alten R, Mischkewitz M, Stefanski AL, Dörner T. Alten R, et al. Z Rheumatol. 2020 Apr;79(3):241-254. doi: 10.1007/s00393-020-00768-5. Z Rheumatol. 2020. PMID: 32219519 Review. German.

4

Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.

Fautrel B, Alten R, Kirkham B, de la Torre I, Durand F, Barry J, Holzkaemper T, Fakhouri W, Taylor PC. Fautrel B, et al. Among authors: alten r. Rheumatol Int. 2018 Jun;38(6):935-947. doi: 10.1007/s00296-018-4005-5. Epub 2018 Mar 21. Rheumatol Int. 2018. PMID: 29564549 Free PMC article. Review.

5

Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1).

Westhovens R, Taylor PC, Alten R, Pavlova D, Enríquez-Sosa F, Mazur M, Greenwald M, Van der Aa A, Vanhoutte F, Tasset C, Harrison P. Westhovens R, et al. Among authors: alten r. Ann Rheum Dis. 2017 Jun;76(6):998-1008. doi: 10.1136/annrheumdis-2016-210104. Epub 2016 Dec 19. Ann Rheum Dis. 2017. PMID: 27993829 Free article. Clinical Trial.

6

Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis.

Caporali R, Allanore Y, Alten R, Combe B, Durez P, Iannone F, Nurmohamed MT, Lee SJ, Kwon TS, Choi JS, Park G, Yoo DH. Caporali R, et al. Among authors: alten r. Expert Rev Clin Immunol. 2021 Jan;17(1):85-99. doi: 10.1080/1744666X.2020.1858803. Epub 2020 Dec 28. Expert Rev Clin Immunol. 2021. PMID: 33305638

7

[Febuxostat or allopurinol in patients with gout : Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)].

Alten R, Mischkewitz M, Nitschmann S. Alten R, et al. Internist (Berl). 2020 May;61(5):530-532. doi: 10.1007/s00108-020-00766-4. Internist (Berl). 2020. PMID: 32130437 German. No abstract available.

8

Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis.

Zrubka Z, Gulácsi L, Brodszky V, Rencz F, Alten R, Szekanecz Z, Péntek M. Zrubka Z, et al. Among authors: alten r. Expert Rev Pharmacoecon Outcomes Res. 2019 Oct;19(5):537-549. doi: 10.1080/14737167.2019.1647104. Epub 2019 Aug 1. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 31340686

9

FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension.

Genovese MC, Glover J, Greenwald M, Porawska W, El Khouri EC, Dokoupilova E, Vargas JI, Stanislavchuk M, Kellner H, Baranova E, Matsunaga N, Alten R. Genovese MC, et al. Among authors: alten r. Arthritis Res Ther. 2019 Dec 12;21(1):281. doi: 10.1186/s13075-019-2046-0. Arthritis Res Ther. 2019. PMID: 31831079 Free PMC article. Clinical Trial.

10

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.

Alten R, Bingham CO 3rd, Cohen SB, Curtis JR, Kelly S, Wong D, Genovese MC. Alten R, et al. BMC Musculoskelet Disord. 2016 May 26;17:231. doi: 10.1186/s12891-016-1082-z. BMC Musculoskelet Disord. 2016. PMID: 27229685 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results